BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32396651)

  • 1. Superimposed mosaicism in tuberous sclerosis complex: a key to understanding all of the manifold manifestations?
    Happle R; Torrelo A
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2511-2517. PubMed ID: 32396651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The concept of type 2 segmental mosaicism, expanding from dermatology to general medicine.
    Happle R
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1075-1088. PubMed ID: 29405433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Segmental type 2 manifestation of autosome dominant skin diseases. Development of a new formal genetic concept].
    Happle R
    Hautarzt; 2001 Apr; 52(4):283-7. PubMed ID: 11382117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive osseous heteroplasia is not a Mendelian trait but a type 2 segmental manifestation of GNAS inactivation disorders: A hypothesis.
    Happle R
    Eur J Med Genet; 2016 May; 59(5):290-4. PubMed ID: 27058263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological Patterns of Skin Lesions in Tuberous Sclerosis Complex: A Panorama.
    Cascarino M; Leclerc-Mercier S
    Dermatopathology (Basel); 2021 Jul; 8(3):236-252. PubMed ID: 34287284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic loss underlies type 2 segmental Hailey-Hailey disease, providing molecular confirmation of a novel genetic concept.
    Poblete-Gutiérrez P; Wiederholt T; König A; Jugert FK; Marquardt Y; Rübben A; Merk HF; Happle R; Frank J
    J Clin Invest; 2004 Nov; 114(10):1467-74. PubMed ID: 15545997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria.
    Roach ES; Gomez MR; Northrup H
    J Child Neurol; 1998 Dec; 13(12):624-8. PubMed ID: 9881533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated and unilateral facial angiofibromas revealing a type 1 segmental postzygotic mosaicism of tuberous sclerosis complex with c.4949_4982del TSC2 mutation.
    Bessis D; Malinge MC; Girard C
    Br J Dermatol; 2018 Jan; 178(1):e53-e54. PubMed ID: 29315486
    [No Abstract]   [Full Text] [Related]  

  • 9. Folliculocystic and Collagen Hamartoma: A Subset of Fibrous Cephalic Plaque.
    Savell AS; Norton K; Heaphy MR
    Cureus; 2021 May; 13(5):e14987. PubMed ID: 34131532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant genodermatoses in adults being heralded by superimposed skin lesions in children.
    Happle R
    Am J Med Genet C Semin Med Genet; 2023 Jun; 193(2):109-115. PubMed ID: 37288730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrous cephalic plaques in tuberous sclerosis complex.
    Oyerinde O; Buccine D; Treichel A; Hong C; Lee CR; Moss J; Darling TN
    J Am Acad Dermatol; 2018 Apr; 78(4):717-724. PubMed ID: 29258863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The categories of cutaneous mosaicism: A proposed classification.
    Happle R
    Am J Med Genet A; 2016 Feb; 170A(2):452-459. PubMed ID: 26494396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folliculocystic and collagen hamartoma of tuberous sclerosis: A new case in a female patient and review of literature.
    Kaplan L; Kazlouskaya V; Ugorji R; Heilman E; Siegel DM; Glick SA
    J Cutan Pathol; 2018 Jan; 45(1):67-70. PubMed ID: 29023848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forehead plaque in a child with epilepsy: A clue for tuberous sclerosis.
    Singanamalla B; Bhagwat C; Madaan P; Saini L; De D
    Trop Doct; 2021 Apr; 51(2):259-260. PubMed ID: 33232218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solitary scalp folliculocystic and collagen hamartoma caused by c.2353C>T TSC2 somatic mutation in a sporadic case of tuberous sclerosis complex with calvarial fibrous dysplasia.
    Qiu F; Luo Y; Zhan AT; Li FG; Fan YM
    Eur J Dermatol; 2023 Apr; 33(2):175-178. PubMed ID: 37431128
    [No Abstract]   [Full Text] [Related]  

  • 16. Congenital segmental lymphedema in tuberous sclerosis complex with associated subependymal giant cell astrocytomas treated with Mammalian target of rapamycin inhibitors.
    Prato G; Mancardi MM; Baglietto MG; Janis S; Vercellino N; Rossi A; Consales A; Raso A; Garrè ML
    J Child Neurol; 2014 Sep; 29(9):NP54-7. PubMed ID: 24056156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene.
    Sampson JR; Maheshwar MM; Aspinwall R; Thompson P; Cheadle JP; Ravine D; Roy S; Haan E; Bernstein J; Harris PC
    Am J Hum Genet; 1997 Oct; 61(4):843-51. PubMed ID: 9382094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal mosaicism, maximal phenotype: Discordance between clinical and molecular findings in two patients with tuberous sclerosis.
    Byers HM; Jensen DM; Glass IA; Bennett JT
    Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):374-378. PubMed ID: 30260069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 segmental manifestation of Hailey-Hailey disease.
    Hwang LY; Lee JB; Richard G; Uitto JJ; Hsu S
    J Am Acad Dermatol; 2003 Oct; 49(4):712-4. PubMed ID: 14512922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrodactyly in tuberous sclerosis complex: Case report and review of the literature.
    Soeiro E Sá M; Moldovan O; Sousa AB
    Am J Med Genet A; 2016 Jul; 170(7):1903-7. PubMed ID: 27112935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.